However, after adjusting for serum levels of IL17, IL10, as well as the other general clinicopathological factors, the risk remained statistically significant for tumor size only (adjusted HR = 2.00, 95% CI 1.09–3.68) (Table 4). Here, IL10 is linked to neoplasm.